Next Article in Journal
Microbial Population Changes and Their Relationship with Human Health and Disease
Next Article in Special Issue
The Revival of the Battle between David and Goliath in the Enteric Viruses and Microbiota Struggle: Potential Implication for Celiac Disease
Previous Article in Journal
Probiotics and Colon Cancer
Review

Probiotics and Prebiotics for the Amelioration of Type 1 Diabetes: Present and Future Perspectives

1
Department of Internal Medicine-Molecular Medicine, Centre for Diabetes, Obesity and Metabolism, Wake Forest School of Medicine, Winston-Salem, NC 27101, USA
2
Department of Microbiology and Immunology, Centre for Diabetes, Obesity and Metabolism, Wake Forest School of Medicine, Winston-Salem, NC 27101, USA
3
Department of Animal Genetics and Breeding, West Bengal University of Animal and Fishery Science, Kolkata 700 037, India
*
Author to whom correspondence should be addressed.
Microorganisms 2019, 7(3), 67; https://doi.org/10.3390/microorganisms7030067
Received: 10 January 2019 / Revised: 19 February 2019 / Accepted: 25 February 2019 / Published: 2 March 2019
(This article belongs to the Collection Feature Papers in Gut Microbiota)
Type 1-diabetes (T1D) is an autoimmune disease characterized by immune-mediated destruction of pancreatic beta (β)-cells. Genetic and environmental interactions play an important role in immune system malfunction by priming an aggressive adaptive immune response against β-cells. The microbes inhabiting the human intestine closely interact with the enteric mucosal immune system. Gut microbiota colonization and immune system maturation occur in parallel during early years of life; hence, perturbations in the gut microbiota can impair the functions of immune cells and vice-versa. Abnormal gut microbiota perturbations (dysbiosis) are often detected in T1D subjects, particularly those diagnosed as multiple-autoantibody-positive as a result of an aggressive and adverse immunoresponse. The pathogenesis of T1D involves activation of self-reactive T-cells, resulting in the destruction of β-cells by CD8+ T-lymphocytes. It is also becoming clear that gut microbes interact closely with T-cells. The amelioration of gut dysbiosis using specific probiotics and prebiotics has been found to be associated with decline in the autoimmune response (with diminished inflammation) and gut integrity (through increased expression of tight-junction proteins in the intestinal epithelium). This review discusses the potential interactions between gut microbiota and immune mechanisms that are involved in the progression of T1D and contemplates the potential effects and prospects of gut microbiota modulators, including probiotic and prebiotic interventions, in the amelioration of T1D pathology, in both human and animal models. View Full-Text
Keywords: autoimmune; diet; diabetes; prebiotics; probiotics; fiber; gut; microbiota; microflora autoimmune; diet; diabetes; prebiotics; probiotics; fiber; gut; microbiota; microflora
Show Figures

Figure 1

MDPI and ACS Style

Mishra, S.; Wang, S.; Nagpal, R.; Miller, B.; Singh, R.; Taraphder, S.; Yadav, H. Probiotics and Prebiotics for the Amelioration of Type 1 Diabetes: Present and Future Perspectives. Microorganisms 2019, 7, 67. https://doi.org/10.3390/microorganisms7030067

AMA Style

Mishra S, Wang S, Nagpal R, Miller B, Singh R, Taraphder S, Yadav H. Probiotics and Prebiotics for the Amelioration of Type 1 Diabetes: Present and Future Perspectives. Microorganisms. 2019; 7(3):67. https://doi.org/10.3390/microorganisms7030067

Chicago/Turabian Style

Mishra, Sidharth, Shaohua Wang, Ravinder Nagpal, Brandi Miller, Ria Singh, Subhash Taraphder, and Hariom Yadav. 2019. "Probiotics and Prebiotics for the Amelioration of Type 1 Diabetes: Present and Future Perspectives" Microorganisms 7, no. 3: 67. https://doi.org/10.3390/microorganisms7030067

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop